High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects.
Nishimura M.
Respir Care. 2016 Apr;61(4):529-41. doi: 10.4187/respcare.04577.
High-Flow Nasal Cannula Oxygen in Adults: An Evidence-based Assessment.
Drake MG.
Ann Am Thorac Soc. 2018 Feb;15(2):145-155. doi: 10.1513/AnnalsATS.201707-548FR.
The role of high flow oxygen therapy in acute respiratory failure.
Masclans JR, Pérez-Terán P, Roca O.
Med Intensiva. 2015 Nov;39(8):505-15. doi: 10.1016/j.medin.2015.05.009. Epub 2015 Oct 1.
Benefits and risks of oxygen therapy during acute medical illness: Just a matter of dose!
Allardet-Servent J, Sicard G, Metz V, Chiche L.
Rev Med Interne. 2019 Oct;40(10):670-676. doi: 10.1016/j.revmed.2019.04.003. Epub 2019 May 1.
Effectiveness of preoxygenation strategies: a systematic review and network meta-analysis.
Crístian de Carvalho C, Iliff HA, Santos Neto JM, Potter T, Alves MB, Blake L, El-Boghdadly K.
Br J Anaesth. 2024 Jul;133(1):152-163. doi: 10.1016/j.bja.2024.02.028. Epub 2024 Apr 9.
High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model.
Duprez F, de Terwangne C, Bellemans V, Poncin W, Reychler G, Sorgente A, Cuvelier G, Mashayekhi S, Wittebole X.
J Clin Monit Comput. 2022 Oct;36(5):1441-1448. doi: 10.1007/s10877-021-00784-z. Epub 2021 Dec 8.
AARC Clinical Practice Guideline: Management of Adult Patients With Oxygen in the Acute Care Setting.
Piraino T, Madden M, Roberts KJ, Lamberti J, Ginier E, Strickland SL.
Respir Care. 2022 Jan;67(1):115-128. doi: 10.4187/respcare.09294. Epub 2021 Nov 2.
Place of high-flow nasal oxygen in nonoperating room anesthesia.
Nay MA, Auvet A.
Curr Opin Anaesthesiol. 2024 Aug 1;37(4):421-426. doi: 10.1097/ACO.0000000000001383. Epub 2024 Apr 30.
Humidity and Inspired Oxygen Concentration During High-Flow Nasal Cannula Therapy in Neonatal and Infant Lung Models.
Chikata Y, Ohnishi S, Nishimura M.
Respir Care. 2017 May;62(5):532-537. doi: 10.4187/respcare.05319. Epub 2017 Feb 7.
Simultaneous reduction of flow and fraction of inspired oxygen (FiO(2)) versus reduction of flow first or FiO(2) first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial).
Kim MC, Lee YJ, Park JS, Cho YJ, Yoon HI, Lee CT, Lee JH, Kim ES.
Trials. 2020 Jan 14;21(1):81. doi: 10.1186/s13063-019-4019-7.
